Evidence map›Paper›PMID 41933321›Full record

ArticleBMC endocrine disorders2026

Association of glucose metabolism with advanced cardiovascular-kidney-metabolic syndrome and prediction model development in type 2 diabetes mellitus.

Qi Sun, Xinyi Yan, Xiaofeng Li, Yilun Lu, Dongqin Wei, Hai Zhang, Caoxu Zhang, Yu Shi, Yunjuan Gu

Abstract read
In one paragraph

Article in BMC endocrine disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Qi Sun *Department of Endocrinology and Metabolism, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China.
Xinyi Yan *Department of Endocrinology, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Qidong Liver Cancer Institute, Nantong, Jiangsu, 226001, China.
Xiaofeng LiDepartment of Endocrinology, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Qidong Liver Cancer Institute, Nantong, Jiangsu, 226001, China.
Yilun LuDepartment of Endocrinology, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Qidong Liver Cancer Institute, Nantong, Jiangsu, 226001, China.
Dongqin WeiDepartment of Endocrinology, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Qidong Liver Cancer Institute, Nantong, Jiangsu, 226001, China.
Hai ZhangDepartment of Endocrinology, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Qidong Liver Cancer Institute, Nantong, Jiangsu, 226001, China.
Caoxu ZhangDepartment of Endocrinology and Metabolism, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China.
Yu ShiDepartment of Endocrinology, Qidong People's Hospital, Affiliated Qidong Hospital of Nantong University, Qidong Liver Cancer Institute, Nantong, Jiangsu, 226001, China. shiyu_qdph@ntu.edu.cn.
Yunjuan GuDepartment of Endocrinology and Metabolism, Affiliated Hospital of Nantong University, Medical School of Nantong University, Nantong, Jiangsu, 226001, China. guyunjuan@ntu.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCardiovascular-Kidney-Metabolic (CKM) syndrome, characterized by progressive dysfunction of the cardiovascular, renal, and metabolic systems, has gained increasing recognition in recent years. However, the relationship between glucose metabolism and advanced CKM stages in type 2 diabetes mellitus (T2DM) remains insufficiently explored.

objectiveTo investigate the association between glucose metabolism and advanced CKM stages, and to develop and validate a prediction model for advanced CKM syndrome in Chinese adults with T2DM.

methodsThis cross-sectional study enrolled 3,410 patients with T2DM, who were classified into CKM stages 1-4. Glucose metabolism was evaluated using fasting and post-load insulin, C-peptide, HOMA-β, disposition index (DI), HOMA-IR, QUICKI, Matsuda index, and ISI. Associations between glucose metabolic indices and advanced CKM stages (stages 3-4) were examined using logistic regression and restricted cubic spline (RCS) models. A prediction model for advanced CKM syndrome was subsequently developed and validated by assessing the area under the receiver operating characteristic curve (AUC), calibration, and decision curve analysis.

resultsAmong the participants, CKM stages 1-4 accounted for 18.6%, 50.8%, 28.8%, and 1.9%, respectively. Advanced CKM stages (3-4) were more prevalent among older and male patients. As CKM stages progressed, markers of insulin resistance (HOMA-IR, fasting insulin, C-peptide, HOMA-β) significantly increased, while β-cell function and insulin sensitivity indices (QUICKI, Matsuda index, ISI) decreased (all p < 0.001). Higher quartiles of fasting insulin, C-peptide, HOMA-IR, and HOMA-β were positively associated with advanced CKM syndrome, while better insulin sensitivity and preserved β-cell function exhibited protective effects. The developed prediction model demonstrated excellent discrimination (AUC = 0.935), strong calibration, and favorable clinical utility.

conclusionsAdvanced CKM syndrome is strongly associated with impaired glucose metabolism in Chinese adults with T2DM. The validated prediction model based on glucose metabolism may facilitate early identification and targeted management of individuals with a high likelihood of advanced CKM syndrome.

Indexed as

BiomarkersBlood GlucoseCardio-Renal SyndromeDiabetes Mellitus, Type 2Metabolic SyndromeChinaCross-Sectional StudiesFemaleFollow-Up StudiesHumansInsulin ResistanceMaleMiddle AgedPrognosisBiomarkersBlood GlucoseCardiovascular-kidney-metabolic syndromeGlucose metabolismPredictionType 2 diabetes mellitus

Identifiers

PMID41933321
PMCPMC13173880

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.